{
  "clinical_study": {
    "title": "A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension",
    "nct_identifier": "NCT05203510",
    "indication": "Pulmonary Arterial Hypertension",
    "intervention": "Parenteral Treprostinil, Oral Treprostinil",
    "study_arms": {
      "intervention": 1,
      "placebo": 0
    },
    "number_of_participants": 52,
    "average_age": null,
    "age_range": [
      "18 Years",
      "N/A"
    ],
    "interventional_drug": [
      {
        "name": "Parenteral Treprostinil",
        "dose": null,
        "frequency": "per schedule specified in the arm description",
        "formulation": "Parenteral"
      },
      {
        "name": "Oral Treprostinil",
        "dose": null,
        "frequency": null,
        "formulation": "Oral"
      }
    ],
    "endpoints": [
      "Change From Baseline in Right Ventricular Ejection Fraction (RVEF), as Measured by Cardiac Magnetic Resonance Imaging (cMRI) at Month 12",
      "Change From Baseline in mPAP at Month 12",
      "Number of Participants With Clinical Improvement From Baseline to Month 12, 24, and 36",
      "Change From Baseline in RV-Pulmonary Artery (PA) Coupling Estimated by the Ratio of Stroke Volume by End Systolic Volume at Month 12",
      "Change From Baseline in RV End-Diastolic Volume Index at Month 12",
      "Change From Baseline in RV Stroke Volume Index at Month 12",
      "Change From Baseline in 6MWD at Month 12, 24, and 36",
      "Change From Baseline in Registry to EValuate EArly and Long-Term PAH Disease Management (REVEAL) Lite 2 Risk Score at Months 12, 24, and 36",
      "Change From Baseline in WHO FC at Months 12, 24, and 36",
      "Change From Baseline in NT-proBNP at Months 12, 24, and 36",
      "Change From Baseline in Borg Dyspnea Score at Months 12, 24, and 36",
      "Change From Baseline in RV-PA Coupling Estimated by the Ratio of Tricuspid Annular Plane Systolic Excursion by Pulmonary Artery Systolic Pressure (TAPSE/PASP) at Months 12, 24, and 36",
      "Survival Rate: Number of Participants who Survived at Months 12, 24, and 36",
      "Change From Baseline in mPAP at Months 24 and 36"
    ],
    "baseline_characteristics": []
  },
  "endpoints": [
    {
      "name": "Change From Baseline in Right Ventricular Ejection Fraction (RVEF), as Measured by Cardiac Magnetic Resonance Imaging (cMRI) at Month 12",
      "description": "",
      "timepoint": "Baseline, Month 12",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in mPAP at Month 12",
      "description": "",
      "timepoint": "Baseline, Month 12",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Number of Participants With Clinical Improvement From Baseline to Month 12, 24, and 36",
      "description": "Clinical improvement is defined as meeting all 3 criteria: - improvement in six-minute walk distance (6MWD) increase ≥10% or ≥30 meters; - improvement in World Health Organization (WHO) functional class (FC) or maintenance of WHO FC I/II; - improvement in N-terminal pro-brain natriuretic peptide (NT-proBNP) decrease ≥30% or \\<300 ng/liter (L).",
      "timepoint": "Baseline to Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in RV-Pulmonary Artery (PA) Coupling Estimated by the Ratio of Stroke Volume by End Systolic Volume at Month 12",
      "description": "",
      "timepoint": "Baseline, Month 12",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in RV End-Diastolic Volume Index at Month 12",
      "description": "",
      "timepoint": "Baseline, Month 12",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in RV Stroke Volume Index at Month 12",
      "description": "",
      "timepoint": "Baseline, Month 12",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in 6MWD at Month 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline, Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in Registry to EValuate EArly and Long-Term PAH Disease Management (REVEAL) Lite 2 Risk Score at Months 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline, Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in WHO FC at Months 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline, Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in NT-proBNP at Months 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline, Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in Borg Dyspnea Score at Months 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline, Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in RV-PA Coupling Estimated by the Ratio of Tricuspid Annular Plane Systolic Excursion by Pulmonary Artery Systolic Pressure (TAPSE/PASP) at Months 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline, Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Survival Rate: Number of Participants who Survived at Months 12, 24, and 36",
      "description": "",
      "timepoint": "Baseline to Months 12, 24, and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    },
    {
      "name": "Change From Baseline in mPAP at Months 24 and 36",
      "description": "",
      "timepoint": "Baseline, Months 24 and 36",
      "arm": null,
      "average_value": null,
      "upper_end": null,
      "lower_end": null,
      "statistical_significance": null
    }
  ],
  "baseline_measures": []
}